IVVD as of Oct 31 · 06:13 ET
IVVDNasdaqBiological Products, (No Diagnostic Substances)

Invivyd, Inc. · Brief

Next report

5 days

Nov 5 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±48.9%▲+5.13%×0.10
quarterimplied−50%0+50%realized×
Q2 FY26±48.9%▲+5.13%×0.10
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

9disclosed supplier and customer ties in SEC filings showing multiple counterpartiesSEC filings
122managers reporting a position in the latest quarterly filings indicating broad reporting ownership13F · Jun 30 '26

Bear2 of 3

46.00%revenue from the largest disclosed customer concentrated with a specialty distributorSEC filings
16managers whose positions together make up most of the reported value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

IVVD report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±53.5% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.